1. Home
  2. OFG vs WVE Comparison

OFG vs WVE Comparison

Compare OFG & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OFG
  • WVE
  • Stock Information
  • Founded
  • OFG 1964
  • WVE 2012
  • Country
  • OFG United States
  • WVE Singapore
  • Employees
  • OFG N/A
  • WVE 268
  • Industry
  • OFG Major Banks
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • OFG Finance
  • WVE Health Care
  • Exchange
  • OFG Nasdaq
  • WVE Nasdaq
  • Market Cap
  • OFG 2.0B
  • WVE 1.7B
  • IPO Year
  • OFG N/A
  • WVE 2015
  • Fundamental
  • Price
  • OFG $41.67
  • WVE $11.13
  • Analyst Decision
  • OFG Buy
  • WVE Strong Buy
  • Analyst Count
  • OFG 3
  • WVE 10
  • Target Price
  • OFG $50.00
  • WVE $21.60
  • AVG Volume (30 Days)
  • OFG 358.3K
  • WVE 734.1K
  • Earning Date
  • OFG 04-17-2025
  • WVE 03-05-2025
  • Dividend Yield
  • OFG 2.88%
  • WVE N/A
  • EPS Growth
  • OFG 10.44
  • WVE N/A
  • EPS
  • OFG 4.23
  • WVE N/A
  • Revenue
  • OFG $629,438,000.00
  • WVE $53,610,000.00
  • Revenue This Year
  • OFG N/A
  • WVE N/A
  • Revenue Next Year
  • OFG $4.48
  • WVE $48.58
  • P/E Ratio
  • OFG $9.87
  • WVE N/A
  • Revenue Growth
  • OFG 0.13
  • WVE N/A
  • 52 Week Low
  • OFG $33.19
  • WVE $4.01
  • 52 Week High
  • OFG $47.66
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • OFG 41.53
  • WVE 44.53
  • Support Level
  • OFG $40.95
  • WVE $10.79
  • Resistance Level
  • OFG $43.69
  • WVE $11.78
  • Average True Range (ATR)
  • OFG 0.99
  • WVE 0.69
  • MACD
  • OFG -0.20
  • WVE 0.05
  • Stochastic Oscillator
  • OFG 23.15
  • WVE 43.95

About OFG OFG Bancorp

OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. It provides services in the region of Puerto Rico.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: